Aminoglycosides and Duct

N/AUnknownNCT04415554

Carmel Medical Center60 enrolled

Overview

The aim of the study is to assess the effect of aminoglycoside treatment on ductal closure in preterms

Study Type

OBSERVATIONAL

Enrollment

Conditions

Patent Ductus Arteriosus

Interventions

echocardiographyDIAGNOSTIC_TEST

echocardiography exam of the infant

Eligibility

Sex: ALLMin age: 30 MinutesMax age: 3 WeeksHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: infants born at or above 32 weeks of gestation \- Exclusion Criteria: * infants who are unlikely to survive or have congenital heart defects

Outcomes

Primary Outcomes

ductal closure

closure of ductus arteriosus

Time frame: 3 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.